Apyx doubles revenue in Q3
November 12, 2019 - Apyx Medical Corp. (Nasdaq: APYX), a Clearwater medical device firm, posted $7.6 million in revenue from continuing operations in the third quarter of 2019, up 106 percent over Q3 2018. The company’s net loss for the three months ended Sept. 30 was $4.3 million, or 13 cents a share. The company, formerly named Bovie Medical, revamped its operations after selling its legacy electrosurgical business in 2018. Apyx expects total revenue in the range of $27.4 million to $27.9 million and a net loss in the range of $20.3 million to $19.8 million for the full year of fiscal 2019, a news release said. Apyx had the best performing stock among Tampa-St. Pete area public companies in 2018 and the stock price has risen about 12 percent since the first of the year.